• Je něco špatně v tomto záznamu ?

Cancer-Associated Substitutions in RNA Recognition Motifs of PUF60 and U2AF65 Reveal Residues Required for Correct Folding and 3' Splice-Site Selection

J. Kralovicova, I. Borovska, M. Kubickova, PJ. Lukavsky, I. Vorechovsky,

. 2020 ; 12 (7) : . [pub] 20200711

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20021984

Grantová podpora
12060 Bloodwise
APVV-18-0096 SRDA
2-0057-18 VEGA
PCIG14-GA-2013-630758 Marie Curie Career Integration Grannt

U2AF65 (U2AF2) and PUF60 (PUF60) are splicing factors important for recruitment of the U2 small nuclear ribonucleoprotein to lariat branch points and selection of 3' splice sites (3'ss). Both proteins preferentially bind uridine-rich sequences upstream of 3'ss via their RNA recognition motifs (RRMs). Here, we examined 36 RRM substitutions reported in cancer patients to identify variants that alter 3'ss selection, RNA binding and protein properties. Employing PUF60- and U2AF65-dependent 3'ss previously identified by RNA-seq of depleted cells, we found that 43% (10/23) and 15% (2/13) of independent RRM mutations in U2AF65 and PUF60, respectively, conferred splicing defects. At least three RRM mutations increased skipping of internal U2AF2 (~9%, 2/23) or PUF60 (~8%, 1/13) exons, indicating that cancer-associated RRM mutations can have both cis- and trans-acting effects on splicing. We also report residues required for correct folding/stability of each protein and map functional RRM substitutions on to existing high-resolution structures of U2AF65 and PUF60. These results identify new RRM residues critical for 3'ss selection and provide relatively simple tools to detect clonal RRM mutations that enhance the mRNA isoform diversity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20021984
003      
CZ-PrNML
005      
20201204093511.0
007      
ta
008      
201125s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cancers12071865 $2 doi
035    __
$a (PubMed)32664474
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kralovicova, Jana $u Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. Institute of Molecular Physiology and Genetics, Center of Biosciences, Slovak Academy of Sciences, 840 05 Bratislava, Slovakia.
245    10
$a Cancer-Associated Substitutions in RNA Recognition Motifs of PUF60 and U2AF65 Reveal Residues Required for Correct Folding and 3' Splice-Site Selection / $c J. Kralovicova, I. Borovska, M. Kubickova, PJ. Lukavsky, I. Vorechovsky,
520    9_
$a U2AF65 (U2AF2) and PUF60 (PUF60) are splicing factors important for recruitment of the U2 small nuclear ribonucleoprotein to lariat branch points and selection of 3' splice sites (3'ss). Both proteins preferentially bind uridine-rich sequences upstream of 3'ss via their RNA recognition motifs (RRMs). Here, we examined 36 RRM substitutions reported in cancer patients to identify variants that alter 3'ss selection, RNA binding and protein properties. Employing PUF60- and U2AF65-dependent 3'ss previously identified by RNA-seq of depleted cells, we found that 43% (10/23) and 15% (2/13) of independent RRM mutations in U2AF65 and PUF60, respectively, conferred splicing defects. At least three RRM mutations increased skipping of internal U2AF2 (~9%, 2/23) or PUF60 (~8%, 1/13) exons, indicating that cancer-associated RRM mutations can have both cis- and trans-acting effects on splicing. We also report residues required for correct folding/stability of each protein and map functional RRM substitutions on to existing high-resolution structures of U2AF65 and PUF60. These results identify new RRM residues critical for 3'ss selection and provide relatively simple tools to detect clonal RRM mutations that enhance the mRNA isoform diversity.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Borovska, Ivana $u Institute of Molecular Physiology and Genetics, Center of Biosciences, Slovak Academy of Sciences, 840 05 Bratislava, Slovakia.
700    1_
$a Kubickova, Monika $u CEITEC, Masaryk University, 625 00 Brno, Czech Republic.
700    1_
$a Lukavsky, Peter J $u CEITEC, Masaryk University, 625 00 Brno, Czech Republic.
700    1_
$a Vorechovsky, Igor $u Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.
773    0_
$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 12, č. 7 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32664474 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201204093509 $b ABA008
999    __
$a ind $b bmc $g 1591692 $s 1112656
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 12 $c 7 $e 20200711 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
GRA    __
$a 12060 $p Bloodwise
GRA    __
$a APVV-18-0096 $p SRDA
GRA    __
$a 2-0057-18 $p VEGA
GRA    __
$a PCIG14-GA-2013-630758 $p Marie Curie Career Integration Grannt
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...